Comparison of the Efficacy of Intranasal Ketamine Versus Intravenous Ketorolac on Acute Non-traumatic Headaches: a Randomized Double-blind Clinical Trial

Overview

Journal Head Face Med

Publisher Biomed Central

Specialties Dentistry
General Medicine
Orthopedics

Date 2022 Jan 4

PMID 34980184

Citations 3

Authors

Hooman Rafiei Sarvari

Hamidreza Baigrezaii

Mohammad Nazarianpirdosti

Amirhossein Meysami

Roya Safari-Faramani

Affiliations

Soon will be listed here.

Abstract

Introduction: Non - traumatic headaches are one of the most common causes of referral to hospital emergency. This study aimed to compare the efficacy of intranasal ketamine and intravenous ketorolac on acute non-traumatic headaches.

Methods: This randomized and double-blind clinical trial was conducted in 2019. One hundred and forty samples were randomly divided into intranasal ketamine (A) and intravenous ketorolac (B). Group (A) received ketamine intranasal (0.75 mg/kg, max 75 mg), and group B received intravenous ketorolac (30 mg). Headache severity was measured on arrival, 30, 60, and 120 min after intervention with Visual Analogue Scale (VAS). The side effects were recorded an hour after the intervention.

Result: The mean difference of pain intensity 30, 60, and 120 min after the intervention between the two groups was statistically significant (p < 0.001). In the first 30 min, significant changes were observed in the VAS levels of the two groups. These changes were significantly greater in the intranasal ketamine group (p < 0.001). Side effects such as fatigue, dizziness, general discomfort, nausea, increased heart rate, and hypertension were significantly higher in the ketamine group (p < 0.05).

Conclusion: Intranasal ketamine and intravenous ketorolac both effectively reduced headaches. However, more analgesic effects of intranasal ketamine in a short time can be considered as a selective approach to reducing headaches.

Trial Registration: IRCT20180108038276N3 , Registered 29 September 2019.

Ethics Committee Reference Number: IR.KUMS.REC.1398.068.

Citing Articles

Human head and neck cancer cell lines response to cold atmospheric plasma activated media is affected by the chemistry of culture media.

di Giacomo V, Balaha M, Pece A, Cela I, Fulgenzi G, Orsini G Heliyon. 2025; 11(1):e41458.

PMID: 39866438 PMC: 11757765. DOI: 10.1016/j.heliyon.2024.e41458.

Effectiveness of Intranasal Analgesia in the Emergency Department.

Zanza C, Saglietti F, Giamello J, Savioli G, Biancone D, Balzanelli M Medicina (Kaunas). 2023; 59(10).

PMID: 37893464 PMC: 10608673. DOI: 10.3390/medicina59101746.

A systematic review of the efficacy of ketamine for craniofacial pain.

Hoydonckx Y, McKechnie T, Peer M, Englesakis M, Kumar P Can J Pain. 2023; 7(1):2210167.

PMID: 37383673 PMC: 10294769. DOI: 10.1080/24740527.2023.2210167.

Narrative Review: Low-Dose Ketamine for Pain Management.

Riccardi A, Guarino M, Serra S, Spampinato M, Vanni S, Shiffer D J Clin Med. 2023; 12(9).

PMID: 37176696 PMC: 10179418. DOI: 10.3390/jcm12093256.

References

Golikhatir I, Cheraghmakani H, Bozorgi F, Jahanian F, Sazgar M, Montazer S . The Efficacy and Safety of Prochlorperazine in Patients With Acute Migraine: A Systematic Review and Meta-Analysis. Headache. 2019; 59(5):682-700. DOI: 10.1111/head.13527. View

Meredith J, Wait S, Brewer K . A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003; 21(3):173-5. DOI: 10.1016/s0735-6757(02)42256-5. View

Assouline B, Tramer M, Kreienbuhl L, Elia N . Benefit and harm of adding ketamine to an opioid in a patient-controlled analgesia device for the control of postoperative pain: systematic review and meta-analyses of randomized controlled trials with trial sequential analyses. Pain. 2016; 157(12):2854-2864. DOI: 10.1097/j.pain.0000000000000705. View

Holinstat M . Normal platelet function. Cancer Metastasis Rev. 2017; 36(2):195-198. PMC: 5709181. DOI: 10.1007/s10555-017-9677-x. View

Visser E, Schug S . The role of ketamine in pain management. Biomed Pharmacother. 2006; 60(7):341-8. DOI: 10.1016/j.biopha.2006.06.021. View

Zitek T, Gates M, Pitotti C, Bartlett A, Patel J, Rahbar A . A Comparison of Headache Treatment in the Emergency Department: Prochlorperazine Versus Ketamine. Ann Emerg Med. 2017; 71(3):369-377.e1. DOI: 10.1016/j.annemergmed.2017.08.063. View

SADOVE M, Shulman M, Hatano S, Fevold N . Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg. 1971; 50(3):452-7. View

Saeedi M, Shahvaran S, Ramezani M, Rafiemanesh H, Karimialavijeh E . Comparing the effects of 3 oxygen delivery methods plus intravenous ketorolac on primary headaches: A randomized clinical trial. Am J Emerg Med. 2019; 38(1):55-59. DOI: 10.1016/j.ajem.2019.04.018. View

Afridi S, Giffin N, Kaube H, Goadsby P . A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013; 80(7):642-7. DOI: 10.1212/WNL.0b013e3182824e66. View

10.

Shrestha R, Pant S, Shrestha A, Batajoo K, Thapa R, Vaidya S . Intranasal ketamine for the treatment of patients with acute pain in the emergency department. World J Emerg Med. 2016; 7(1):19-24. PMC: 4786493. DOI: 10.5847/wjem.j.1920-8642.2016.01.003. View

11.

Etchison A, Bos L, Ray M, McAllister K, Mohammed M, Park B . Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial. West J Emerg Med. 2018; 19(6):952-960. PMC: 6225951. DOI: 10.5811/westjem.2018.8.37875. View

12.

Persson J . Ketamine in pain management. CNS Neurosci Ther. 2013; 19(6):396-402. PMC: 6493592. DOI: 10.1111/cns.12111. View

13.

Straube A, Andreou A . Primary headaches during lifespan. J Headache Pain. 2019; 20(1):35. PMC: 6734460. DOI: 10.1186/s10194-019-0985-0. View

14.

Allen C, Ivester Jr J . Ketamine for Pain Management-Side Effects & Potential Adverse Events. Pain Manag Nurs. 2017; 18(6):372-377. DOI: 10.1016/j.pmn.2017.05.006. View

15.

Abbasi M, Dehghani M, Keefe F, Jafari H, Behtash H, Shams J . Spouse-assisted training in pain coping skills and the outcome of multidisciplinary pain management for chronic low back pain treatment: a 1-year randomized controlled trial. Eur J Pain. 2012; 16(7):1033-43. DOI: 10.1002/j.1532-2149.2011.00097.x. View

16.

Hawker G, Mian S, Kendzerska T, French M . Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain.... Arthritis Care Res (Hoboken). 2012; 63 Suppl 11:S240-52. DOI: 10.1002/acr.20543. View

17.

Gopalraju P, Lalitha R, Prasad K, Ranganath K . Comparative study of intravenous Tramadol versus Ketorolac for preventing postoperative pain after third molar surgery--a prospective randomized study. J Craniomaxillofac Surg. 2013; 42(5):629-33. DOI: 10.1016/j.jcms.2013.09.004. View

18.

Carlsson A . Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983; 16(1):87-101. DOI: 10.1016/0304-3959(83)90088-X. View

19.

Forouzanfar M, Mohammadi K, Hashemi B, Safari S . Comparison of Intravenous Ibuprofen with Intravenous Ketorolac in Renal Colic Pain Management; A Clinical Trial. Anesth Pain Med. 2019; 9(1):e86963. PMC: 6412918. DOI: 10.5812/aapm.86963. View

20.

Lipton R, Bigal M, Steiner T, Silberstein S, Olesen J . Classification of primary headaches. Neurology. 2004; 63(3):427-35. DOI: 10.1212/01.wnl.0000133301.66364.9b. View